Ridgefield, CT – The Headquarters for the United States

The Boehringer Ingelheim U.S. headquarters in Ridgefield, CT.

Established in the United States in 1971, Boehringer Ingelheim broke ground on its Ridgefield, Connecticut site in April 1977. Just an hour’s drive from New York City, this scenic campus serves as the U.S. headquarters and a central hub for the Human Pharmaceuticals business. Home to more than 2,000 employees, the Ridgefield site includes the Innovation Unit—an advanced research and development center dedicated to scientific progress and patient care. Spanning over 300 picturesque acres, the campus features 14 buildings, including:

• Research and Development Building Complex
• Briar Ridge Center Complex
• Administrative Office Building – the U.S. Corporate Headquarters

A leader in sustainability, the Ridgefield site is proudly carbon neutral. Its entire electricity supply comes from 100% renewable sources, including hydroelectric and solar power.

Shanghai

Shanghai, China, serves as an important hub within the global network of all three business areas – Human Pharma, Animal Health and Biopharmaceutical Contract Manufacturing.

Biberach

The largest research and development center of Boehringer Ingelheim is located in Biberach, Germany. It is one of the largest sites in Europe for biopharmaceutical manufacturing.

Ingelheim

The company headquarters of Boehringer Ingelheim are located in Ingelheim, Germany. It is the largest site, serving both launch and commercial supply.

References